Industry Insights: Healthcare 18th July
Industry Insights Healthcare: 18/07/25 In this week’s insights post, we discuss three of the most recent advancements and hot topics in the healthcare industry. Bringing sun exposure-related risks to light As UV (ultraviolet) Safety Awareness Month takes centre stage, healthcare professionals have once again reminded the public of the critical importance of sun safety. Excessive […]
Industry Insights: Healthcare 27th June
Industry Insights Healthcare: 6/06/25 This week’s insights post discusses three of the most recent medication and device approvals in the healthcare industry. FDA approves new drug for COPD associated with eosinophilic inflammation The US Food and Drug Administration (FDA) has granted approval for GSK’s monoclonal antibody Nucala (mepolizumab) as an add-on maintenance treatment for adults […]
Industry Insights: Healthcare 6th June
Industry Insights Healthcare: 6/06/25 This week’s insights post discusses three of the most recent medication and device approvals in the healthcare industry. FDA approves new drug for COPD associated with eosinophilic inflammation The US Food and Drug Administration (FDA) has granted approval for GSK’s monoclonal antibody Nucala (mepolizumab) as an add-on maintenance treatment for […]
Industry Insights: Healthcare 16th May
Industry Insights Healthcare: 16/05/25 In this week’s insights post, we elaborate on three of the most recent developments in the healthcare industry. Trump executive order aims to reduce US drug prices by 59% On 12 May 2025, US President Donald J. Trump signed an executive order to reduce prescription drug prices for American patients. […]
Industry Insights: Healthcare 27th April
Industry Insights Healthcare: 27/04/25 This week’s insights post focuses on three of the most recent developments in the healthcare industry. FDA approves new drug for muscle-invasive bladder cancer The US Food and Drug Administration (FDA) has approved Imfinzi (durvalumab), AstraZeneca’s PD-L1 inhibitor, as the first and only perioperative immunotherapy for muscle-invasive bladder cancer (MIBC). […]
Industry Insights: Healthcare 16th March
Industry Insights Healthcare: 16/03/25 In this week’s insights, we discuss three of the most recent developments in the healthcare industry. FDA approves new antibiotics for urinary tract infections The US Food and Drug Administration (FDA) recently approved gepotidacin (Blujepa), a class of antibiotics, for the treatment of uncomplicated urinary tract infections (uUTIs) in females aged […]
Industry Insights: Healthcare 23rd February
Industry Insights Healthcare: 23/02/25 In this week’s insights, we discuss three of the latest pharmaceutical approvals in the healthcare industry. FDA approves the first drug for Niemann-Pick disease, type C The US Food and Drug Administration (FDA) has approved arimoclomol (Miplyffa) for the treatment of Niemann-Pick disease, type C in adults and children 2 […]
Industry Insights: Healthcare 22nd November
Industry Insights Healthcare: 22/11/24 In this week’s insights, we discuss three of the latest developments in the healthcare industry. Study discovers genetic factors behind testicular cancer As we head into the second half of November, we turn our attention to the annual Movember activity, which focusses on increasing awareness of various aspects of men’s health. […]
Industry Insights: Healthcare 31st October
Industry Insights Healthcare: 31/10/24 This week’s insights focus on three of the latest developments in the healthcare industry. Advancing breast cancer care with HER2-targeted therapies Breast Cancer Awareness Month marks a period of the year in which healthcare professionals and organisations worldwide aim to raise awareness of the importance of diagnosing and treating breast […]
Industry Insights: Healthcare 10th October
Industry Insights Healthcare: 10/10/24 In this week’s insights, we will briefly summarise three of the latest advancements and approvals in the healthcare industry. The FDA approves the first self-administered nasal spray flu vaccine The US Food and Drug Administration (FDA) has approved FluMist (AstraZeneca), a nasal spray flu vaccine, for self-administration by adult patients up […]
Industry Insights: Healthcare 19th September
Industry Insights Healthcare: 19/09/24 In this week’s insights, we will briefly summarise three of the latest developments in the healthcare industry. FDA approves updated COVID-19 vaccines from Pfizer and ModernaThe US Food and Drug Administration (FDA) has approved updated mRNA COVID-19 vaccines from Pfizer and Moderna designed to target the currently circulating SARS-CoV-2 variant (an […]
Industry Insights: Healthcare 29th August
Industry Insights Healthcare: 29/08/24 This week’s insights focus on three of the latest findings and developments in the healthcare industry. Encoding genes outside the genome: Is it possible?A new study by researchers at Columbia University revealed that bacteria can create free-floating and temporary genes that exist outside of their genomes. The researchers discovered this phenomenon […]
